xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"
32.—[F1(1) A routine application [F2may be deferred] where paragraph (2) applies to the relevant premises.]
(2) This paragraph applies where the relevant premises are premises or part of premises, or are located within an area, designated under—
(a)regulation 99; or
(b)regulation 4 of the 2006 Regulations M1 (designation of priority neighbourhoods or premises),
and that designation has neither been varied so that it no longer applies to the relevant premises nor been cancelled.
(3) For the purposes of this regulation, “the relevant premises” are—
(a)the listed chemist premises or proposed listed chemist premises in the application; or
(b)as regards an application for inclusion in a pharmaceutical list by a person not already included, if no particular premises are proposed for listing in the application, premises located at the best estimate that [F3NHS England] is able to make as to where the proposed listed chemist premises would be, having regard to the best estimate given by the applicant under paragraph 1(7)(a)(ii) of Schedule 2.
Textual Amendments
F1Reg. 32(1) substituted (1.4.2014) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2014 (S.I. 2014/417), regs. 1, 11
F2Words in reg. 32(1) substituted (1.3.2015) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment and Transitional Provision) Regulations 2015 (S.I. 2015/58), regs. 1(1), 3 (with reg. 10)
F3Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1
Marginal Citations
M1Prior to its revocation, regulation 4 was amended by S.I. 2009/599 and 2010/914.